Company intelligence / Profile preview

Derma Sciences

Princeton/Plainsboro, New Jersey, United Statesthedermasciences.com ↗

Ownership: Public · DSCI
Employees: ~200
Development stage: Commercial

Overview

Derma Sciences was a commercial-stage company specializing in advanced wound and burn care products. Its amniotic tissue-based technologies were used for regenerative medicine applications. The company had a significant presence in the advanced wound care market prior to its acquisition by Integra LifeSciences in 2017.

Therapeutic areas: Dermatology
Modalities: BiologicDevice
Industry: Biotech

Drug pipeline

4 assets

MEDIHONEY

Commercial

Indications: Wounds, Burns

3 more assets in the full pipeline.

Request access →

Financials

Market cap: $0
Total revenue: $13.1M
Enterprise value: $8.2B

Beyond the preview

Go deeper on Derma Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Derma Sciences.

Explore the full profile